Otsing - TalTech teadusportaal

Publikatsioonid
Profiilid
Uurimisrühmad
Registrid
Abi ja info
Switch to English

Publikatsioonid

Publikatsioonid

Otsing

Valitud kirjed 0

anti-GBM disease (võtmesõna)

—

—

—

—

Lisa tingimus Liitotsing filter

Tühista

teaviku laadid

raamat ..

artikkel ajakirjas ..

artikkel ajalehes ..

artikkel kogumikus ..

dissertatsioon ..

Open Access ..

Teaduspublikatsioon ..

aasta

Toon andmeid..

Toon andmeid..

TTÜ struktuuriüksus

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Tühista

Kirjeid leitud 3
Vaata veel.. (5/111)
Ekspordi

ekspordi kõik päringu tulemused (3)
Salvesta TXT fail

prindi
Märgitud kirjetega toimetamiseks ava valitud kirjed

kuva

reasta
1

artikkel ajakirjas EST / artikkel ajakirjas ENG

Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease : an open-label phase 2a studyUhlin, Nils Fredrik Arne; Szpirt, Wladimir; Kronbichler, Andreas; Bruchfeld, Annette; Soveri, Inga; Rostaing, Lionel; Daugas, Eric; Lionet, Arnaud; Kamar, Nassim; Rafat, CedricJournal of the American Society of Nephrology2022 / p. 829-838 https://doi.org/10.1681/ASN.2021111460 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
2

artikkel ajakirjas EST / artikkel ajakirjas ENG

The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane diseaseSoveri, Inga; Molne, Johan; Uhlin, Nils Fredrik Arne; Nilsson, Thomas; Kjellman, Christian; Sonessonm, Elisabeth; Segelmark, MartenKidney International2019 / p. 1234-1238 https://doi.org/10.1016/j.kint.2019.06.019 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
3

artikkel ajakirjas EST / artikkel ajakirjas ENG

Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatmentTyrberg, Linnea; Andersson, Fanny; Uhlin, Nils Fredrik Arne; Hellmark, Thomas; Segelmark, MartenNephrology Dialysis Transplantation2024 / p. 45-54 https://doi.org/10.1093/ndt/gfad132 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG

Kirjeid leitud 3, kuvan 1 - 3

1. anti-GBM disease
2. Alzheimer’s disease
3. Alzheimer's disease
4. autoantibody-mediated renal disease
5. autosomal dominant polycystic kidney disease
6. cardiovascular disease
7. celiac disease
8. cerebrovascular disease
9. chronic kidney disease
10. chronic obstructive pulmonary disease
11. coronary artery disease
12. coronary artery disease (CAD)
13. coronary disease
14. coronary heart disease
15. disease
16. disease diagnosis
17. disease model
18. disease models
19. disease progression
20. disease resistance
21. disease-modifying therapy
22. End stage kidney disease
23. end stage renal disease
24. end-stage kidney disease
25. end-stage renal disease
26. garment workers and patients with occupational disease
27. gas bubble disease
28. genetic predisposition to disease
29. heart disease risk factors
30. human disease
31. Huntington’s disease
32. infectious disease
33. in-transit disease
34. late blight disease
35. loco-regionally metastatic disease
36. lyme disease
37. mechanisms of disease
38. Menkes disease
39. Metabolic dysfunction-associated steatotic liver disease
40. molecular bases of disease
41. NAFLD (non-alcoholic fatty liver disease)
42. neurodegenerative disease
43. neuromuscular disease
44. non-alcoholic fatty liver disease
45. oat striate and red disease
46. Parkinson disease
47. Parkinson’s disease
48. Parkinson’s disease machine learning
49. Parkinson's disease
50. physical overload disease
51. preclinical Alzheimer disease
52. renal disease
53. stable coronary heart disease
54. stereotypy of disease
55. subclinical cardiovascular disease
56. Wilson disease
57. Wilson’s disease
58. von Willebrand disease
59. anti-abuse
60. anti-abuse rule
61. anti-armor mine
62. anti-bacterial agents
63. anti-CD20 monoclonal antibodies
64. anti-competitive agreement
65. anti-H1N1 antibodies
66. anti-lock braking system
67. anti–lock braking system
68. anti-money laundering
69. anti-money laundering (AML)
70. anti-monotonicity
71. Anti-Muslim prejudice
72. anti-oxidant content
73. anti-oxidative activity
74. anti-P2X4 mAb
75. anti-quorum sensing
76. Anti-Str. uberis antibodies
77. Anti-TrustRank
78. general anti-abuse rule

1. Alber, Anti
2. Allikvee, Anti
3. Gruno, Anti
4. Haavajõe, Anti
5. Hamburg, Anti
6. Kalda, Anti
7. Kuiv, Anti
8. Kukkela, Anti
9. Kuus, Anti
10. Liiv, Anti
11. Liiva, Anti
12. Look, Anti
13. Naulainen, Anti
14. Palmi, Anti
15. Rohumaa, Anti
16. Ronk, Anti
17. Saar, Anti
18. Sullin, Anti
19. Viikna, Anti

1. Haavajõe, Anti
2. Hamburg, Anti
3. Haugas, Anti
4. Kuiv, Anti
5. Perkson, Anti
6. Puusepp, Anti, 1969-
7. Siinmaa, Anti
8. Viikna, Anti, 1944-2023

1. Alber, Anti
2. Haavajõe, Anti
3. Hamburg, Anti
4. Rohumaa, Anti
5. Viikna, Anti 1944-2023

1. European Anti-Fraud Office

vaste

reasta

Otsing
Valikud 0

ilmumisaasta

autor

TTÜ struktuuriüksus

märksõna

seeria-sari

tema kohta

võtmesõna

TalTech Raamatukogu

Akadeemia tee 1

13519

TalTech koduleht TalTech Raamatukogu koduleht Digikogu Digiteek Teadusandmed

6203551

data@taltech.ee

TalTech Raamatukogu